China Biologic Products (CBPO) Reports Q3 EPS of $0.96
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq ease from record highs as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts CBPO Hot Sheet
Join SI Premium – FREE
China Biologic Products (NASDAQ: CBPO) reported Q3 EPS of $0.96, versus $1.38 reported last year. Revenue for the quarter came in at $119.1 million versus the consensus estimate of $99.6 million.
- Board of Directors Approves $100 Million Share Repurchase Program
- The Company reiterates its previously revised full year 2018 forecast.
For earnings history and earnings-related data on China Biologic Products (CBPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Some Said Inflation Risks Had Become More Skewed To Upside - FOMC Minutes
- Yorkville Ives Starts Telos Corp. (TLS) at Outperform
- Fairfax and Wittington to acquire Boots for $8.9 billion
Create E-mail Alert Related Categories
Earnings, Stock BuybacksRelated Entities
Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
